AT&T Series A
T.PRA
5 hedge funds and large institutions have $1.14M invested in AT&T Series A in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
1% less capital invested
Capital invested by funds: $1.16M → $1.14M (-$12.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSMHT
Thurston Springer Miller Herd & Titak
Indianapolis,
Indiana
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$4.21K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.28K |
T.PRA Hedge Fund Activity: Q1 2025 in Review
5 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in AT&T Series A (T.PRA) for Q1 2025, worth a combined $1.14M — down 1.1% from $1.16M a quarter earlier.
Fund positioning in T.PRA was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Thurston Springer Miller Herd & Titak, opening a new position worth an estimated $12.6K. The largest seller was Tucker Asset Management, exiting entirely with an estimated $4.21K sold.
- 5 institutional investors held AT&T Series A (T.PRA) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.14M of AT&T Series A stock for Q1 2025, down 1.1% quarter-over-quarter.
- 1 fund opened new AT&T Series A positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest AT&T Series A buyer in Q1 2025 was Thurston Springer Miller Herd & Titak, an estimated $12.6K added.
- The largest AT&T Series A seller in Q1 2025 was Tucker Asset Management, an estimated $4.21K sold.
Based on aggregated 13F filings for Q1 2025.